Infinity Pharmaceuticals | INFI - Gross Profit On Sales


Infinity Pharmaceuticals reported $231K in Gross Profit on Sales for its fiscal quarter ending in June of 2023.





Gross Profit On Sales Change Date
AbbVie USD 10.47B 605M Sep/2025
Amgen USD 6.48B 307M Sep/2025
AstraZeneca USD 12.39B 5M Dec/2025
Bristol-Myers Squibb USD 8.79B 110M Sep/2025
Cipla INR 41.64B 6.31B Dec/2025
Clal Biotechnology ILS -857K 1.42M Jun/2022
Compugen USD 63.8M 63.56M Dec/2025
CSL USD 4.46B 2.71B Dec/2025
Eisai JPY 168.85B 17.02B Dec/2025
Eli Lilly USD 14.59B 1.48B Sep/2025
Gilead Sciences USD 6.31B 106M Dec/2025
GlaxoSmithKline GBP 6.18B 106M Dec/2025
Grifols EUR 766.49M 39.74M Dec/2024
Incyte USD 1.17B 217.51M Mar/2026
Infinity Pharmaceuticals USD 231K 59K Jun/2023
Ionis Pharmaceuticals USD 195M 40M Dec/2025
J&J USD 17.24B 642M Mar/2026
Novartis USD 10.25B 570M Dec/2025
Pfizer USD 3.54B 7.61B Sep/2025
Plus Therapeutics 1.37M 30K Dec/2025
Roche Holding CHF 22.09B 10.04B Dec/2025
TG Therapeutics USD 154.43M 20.81M Dec/2025